New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 4, 2014
06:57 EDTBDSIBioDelivery Sciences risk/reward profile favorable, says William Blair
William Blair reiterates an Outperform rating on shares of BioDelivery Sciences ahead of the June 7 PDUFA date for Bunavail, the company's buprenorphine/naloxone sublingual film for the treatment of opioid addiction. The firm says the FDA has been focused on new therapies for opioid addiction given the current opioid-abuse crisis. It views the risk/reward for BioDelivery shares as favorable and has a $16 price target for the stock.
News For BDSI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 27, 2015
09:37 EDTBDSIActive equity options trading on open
Subscribe for More Information
March 26, 2015
13:46 EDTBDSIBioDelivery Sciences volatility elevated
BioDelivery Sciences April call option implied volatility is at 126, May is at 101, June is at 82; compared to its 26-week average of 78 according to Track Data, suggesting large near term price movement.
March 20, 2015
15:16 EDTBDSIBioDelivery Sciences April volatility elevated
Subscribe for More Information
March 17, 2015
09:25 EDTBDSIOn The Fly: Pre-market Movers
Subscribe for More Information
March 16, 2015
19:00 EDTBDSIOn The Fly: After Hours Movers
Subscribe for More Information
16:12 EDTBDSIBioDelivery Sciences reports Q4 EPS (51c), consensus (33c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use